{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:02:31Z","timestamp":1778889751239,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01 AT010508"],"award-info":[{"award-number":["R01 AT010508"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA046345"],"award-info":[{"award-number":["P30DA046345"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA022975"],"award-info":[{"award-number":["T32 DA022975"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA042998"],"award-info":[{"award-number":["K01DA042998"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003553","name":"Gaelic Athletic Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004823","name":"Connecticut State Department of Mental Health and Addiction Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopsych.2024.09.028","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T20:03:48Z","timestamp":1728590628000},"page":"651-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vitamin D\u2019s Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A\u00a0Clinical Translational [11C]-PHNO Positron Emission Tomography Study"],"prefix":"10.1016","volume":"97","author":[{"given":"Patrick D.","family":"Worhunsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella M.","family":"Mignosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Dominique","family":"Gallezot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabeel B.","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Stryjewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laya","family":"Jalilian-Khave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Trinko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph J.","family":"DiLeone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Malison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo A.","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2024.09.028_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02245330","article-title":"Striatal D2 dopamine receptor binding characteristics in\u00a0vivo in patients with alcohol dependence","volume":"116","author":"Hietala","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2024.09.028_bib2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1530-0277.1996.tb05936.x","article-title":"Decreases in dopamine receptors but not in dopamine transporters in alcoholics","volume":"20","author":"Volkow","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2024.09.028_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1176\/appi.ajp.2010.10050748","article-title":"Imaging dopamine transmission in cocaine dependence: Link between neurochemistry and response to treatment","volume":"168","author":"Martinez","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biopsych.2005.04.044","article-title":"Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum","volume":"58","author":"Martinez","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.biopsych.2011.08.024","article-title":"Deficits in dopamine D2 receptors and presynaptic dopamine in heroin dependence: Commonalities and differences with other types of addiction","volume":"71","author":"Martinez","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/npp.2013.192","article-title":"Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: A positron emission tomography study with [11C]-(+)-PHNO","volume":"39","author":"Payer","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2024.09.028_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1176\/ajp.147.6.719","article-title":"Effects of chronic cocaine abuse on postsynaptic dopamine receptors","volume":"147","author":"Volkow","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib8","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","article-title":"Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex","volume":"158","author":"Volkow","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mp.2011.86","article-title":"Decreased dopamine activity predicts relapse in methamphetamine abusers","volume":"17","author":"Wang","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib10","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1523\/JNEUROSCI.3765-09.2009","article-title":"Striatal dopamine d2\/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity","volume":"29","author":"Lee","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.09.028_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/syn.10137","article-title":"Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study","volume":"46","author":"Volkow","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2024.09.028_bib12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/ajp.156.9.1440","article-title":"Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels","volume":"156","author":"Volkow","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/oby.2011.27","article-title":"Enhanced striatal dopamine release during food stimulation in binge eating disorder","volume":"19","author":"Wang","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.biopsych.2024.09.028_bib14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biopsych.2005.03.036","article-title":"In\u00a0vivo neuroreceptor imaging in attention-deficit\/hyperactivity disorder: A focus on the dopamine transporter","volume":"57","author":"Spencer","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.64.8.932","article-title":"Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit\/hyperactivity disorder","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jama.2009.1308","article-title":"Evaluating dopamine reward pathway in ADHD: Clinical implications","volume":"302","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2024.09.028_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jamapsychiatry.2023.3985","article-title":"Treatment outcomes with licensed and unlicensed stimulant doses for adults with attention-deficit\/hyperactivity disorder: A systematic review and meta-analysis","volume":"81","author":"Farhat","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib21","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00213-020-05563-3","article-title":"Prescription psychostimulants for the treatment of stimulant use disorder: A systematic review and meta-analysis","volume":"237","author":"Tardelli","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2024.09.028_bib22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/add.15242","article-title":"Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer?","volume":"116","author":"Brandt","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2024.09.028_bib23","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0122-15.2016","article-title":"Vitamin D3: A role in dopamine circuit regulation, diet-induced obesity, and drug consumption","volume":"3","author":"Trinko","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.biopsych.2024.09.028_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2013.01.035","article-title":"The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain","volume":"236","author":"Cui","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2024.09.028_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mce.2017.05.035","article-title":"Vitamin D and the brain: Genomic and non-genomic actions","volume":"453","author":"Cui","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.biopsych.2024.09.028_bib26","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1460-9568.2006.04637.x","article-title":"Re-examining the ontogeny of substantia nigra dopamine neurons","volume":"23","author":"Gates","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2024.09.028_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neulet.2010.09.057","article-title":"Maternal vitamin D deficiency alters the expression of genes involved in dopamine specification in the developing rat mesencephalon","volume":"486","author":"Cui","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2024.09.028_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-4328(02)00185-7","article-title":"Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity","volume":"136","author":"Eells","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2024.09.028_bib29","doi-asserted-by":"crossref","first-page":"15619","DOI":"10.1073\/pnas.2635658100","article-title":"p57(Kip2) cooperates with Nurr1 in developing dopamine cells","volume":"100","author":"Joseph","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2024.09.028_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbr.2015.03.008","article-title":"Maternal vitamin D deficiency alters fetal brain development in the BALB\/c mouse","volume":"286","author":"Hawes","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2024.09.028_bib31","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s12035-017-0497-3","article-title":"Developmental vitamin D (DVD) deficiency reduces Nurr1 and TH expression in post-mitotic dopamine neurons in rat mesencephalon","volume":"55","author":"Luan","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2024.09.028_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)02450-7","article-title":"Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats","volume":"904","author":"Wang","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2024.09.028_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1196\/annals.1369.023","article-title":"Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine","volume":"1074","author":"Cass","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2024.09.028_bib34","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/00001756-199609020-00023","article-title":"1,25-dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor","volume":"7","author":"Naveilhan","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2024.09.028_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062040","article-title":"Calcitriol imparts neuroprotection in\u00a0vitro to midbrain dopaminergic neurons by upregulating GDNF expression","volume":"8","author":"Orme","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2024.09.028_bib36","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1523\/JNEUROSCI.23-12-05141.2003","article-title":"Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in\u00a0vivo","volume":"23","author":"Oo","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2024.09.028_bib37","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2024.09.028_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in\u00a0vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2024.09.028_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/1028415X.2019.1665854","article-title":"Protective effects of vitamin D on neurophysiologic alterations in brain aging: Role of brain-derived neurotrophic factor (BDNF)","volume":"24","author":"Khairy","year":"2021","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.biopsych.2024.09.028_bib40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/jnr.20824","article-title":"Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons","volume":"83","author":"Taniura","year":"2006","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.biopsych.2024.09.028_bib41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1043-2760(01)00547-1","article-title":"New clues about vitamin D functions in the nervous system","volume":"13","author":"Garcion","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2024.09.028_bib42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2024.09.028_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1210\/jcem-59-2-202","article-title":"An experimental human model of 1,25-dihydroxyvitamin D-mediated hypercalciuria","volume":"59","author":"Broadus","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2024.09.028_bib44","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1359\/jbmr.1999.14.10.1789","article-title":"No difference in intestinal strontium absorption after an oral or an intravenous 1,25(OH)2D3 bolus in normal subjects. For the European Study Group on Vitamin D in children with renal failure","volume":"14","author":"Bianchi","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.biopsych.2024.09.028_bib45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/17.5.829","article-title":"Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men","volume":"17","author":"Brandi","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.biopsych.2024.09.028_bib46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1200\/JCO.2006.06.8197","article-title":"Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT Investigators","volume":"25","author":"Beer","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.biopsych.2024.09.028_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41386-019-0567-5","article-title":"Serotonin release measured in the human brain: A PET study with [11C]CIMBI-36 and d-amphetamine challenge","volume":"45","author":"Erritzoe","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2024.09.028_bib48","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0893-133X(02)00366-4","article-title":"Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: A PET\/[11C]raclopride study in healthy men","volume":"27","author":"Leyton","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2024.09.028_bib49","first-page":"1182","article-title":"SPECT imaging of striatal dopamine release after amphetamine challenge","volume":"36","author":"Laruelle","year":"1995","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biopsych.2024.09.028_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","article-title":"Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria","volume":"49","author":"Drevets","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib51","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2024.09.028_bib52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/syn.20235","article-title":"Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine","volume":"59","author":"Schiffer","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2024.09.028_bib53","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1046\/j.0953-816X.2003.03067.x","article-title":"Can a therapeutic dose of amphetamine during pre-adolescence modify the pattern of synaptic organization in the brain?","volume":"18","author":"Diaz Heijtz","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2024.09.028_bib54","series-title":"Encyclopedia of Sleep and Circadian Rhythms","first-page":"506","article-title":"The role of pharmacological interventions for sleep deprivation and restriction","author":"Alger","year":"2023"},{"key":"10.1016\/j.biopsych.2024.09.028_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0022-3565(25)26118-3","article-title":"Methods for evaluating addiction liability. (A) \"Attitude\" of opiate addicts toward opiate-like drugs. (B) a short-term \"direct\" addiction test","volume":"133","author":"Fraser","year":"1961","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2024.09.028_bib56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00428897","article-title":"Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment","volume":"44","author":"Van Kammen","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.biopsych.2024.09.028_bib57","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2967\/jnumed.113.132928","article-title":"Parametric Imaging and Test-Retest Variability of 11C-(+)-PHNO Binding to D\u2082\/D\u2083 Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner","volume":"55","author":"Gallezot","year":"2014","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biopsych.2024.09.028_bib58","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1021\/jm050155n","article-title":"Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in\u00a0vivo imaging of the dopamine D2 high-affinity state with positron emission tomography","volume":"48","author":"Wilson","year":"2005","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2024.09.028_bib59","first-page":"3281","article-title":"Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT","volume":"5","author":"Carson","year":"2003","journal-title":"IEEE"},{"key":"10.1016\/j.biopsych.2024.09.028_bib60","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/01.WCB.0000033967.83623.34","article-title":"Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging","volume":"22","author":"Wu","year":"2002","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2024.09.028_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giae049","article-title":"CAT: A computational anatomy toolbox for the analysis of structural MRI data","volume":"13","author":"Gaser","year":"2024","journal-title":"Gigascience"},{"key":"10.1016\/j.biopsych.2024.09.028_bib62","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","article-title":"Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy","volume":"54","author":"Tziortzi","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2024.09.028_bib64","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/1097-0142(20010615)91:12<2431::AID-CNCR1278>3.0.CO;2-3","article-title":"A\u00a0Phase I trial of pulse calcitriol in patients with refractory malignancies: Pulse dosing permits substantial dose escalation","volume":"91","author":"Beer","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.biopsych.2024.09.028_bib65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00280-006-0299-1","article-title":"Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer","volume":"59","author":"Beer","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.biopsych.2024.09.028_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-0173(91)90007-U","article-title":"Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity","volume":"16","author":"Kalivas","year":"1991","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.biopsych.2024.09.028_bib67","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0006-3223(98)00168-1","article-title":"Enhanced behavioral response to repeated d-amphetamine and personality traits in humans","volume":"44","author":"Sax","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib68","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0006-3223(95)00497-1","article-title":"Enhanced response to repeated d-amphetamine challenge: Evidence for behavioral sensitization in humans","volume":"40","author":"Strakowski","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: An incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.biopsych.2024.09.028_bib70","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neubiorev.2003.11.001","article-title":"Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs","volume":"27","author":"Vezina","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2024.09.028_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis","volume":"396","author":"Robinson","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2024.09.028_bib72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/syn.890190108","article-title":"Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats","volume":"19","author":"Paulson","year":"1995","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2024.09.028_bib73","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archpsyc.63.12.1386","article-title":"Modeling sensitization to stimulants in humans: An [11C]raclopride\/positron emission tomography study in healthy men","volume":"63","author":"Boileau","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2024.09.028_bib74","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/hbm.20392","article-title":"Brain region binding of the D2\/3 agonist [11C]-(+)-PHNO and the D2\/3 antagonist [11C]raclopride in healthy humans","volume":"29","author":"Graff-Guerrero","year":"2008","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.biopsych.2024.09.028_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/jcbfm.2011.115","article-title":"Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans","volume":"32","author":"Shotbolt","year":"2012","journal-title":"J\u00a0Cereb Blood Flow Metab"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322324016573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322324016573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:55:21Z","timestamp":1778241321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322324016573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0006322324016573"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2024.09.028","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D\u2019s Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A\u00a0Clinical Translational [11C]-PHNO Positron Emission Tomography Study","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2024.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}